Guerrant Richard L, Carneiro-Filho Benedito A, Dillingham Rebecca A
Center for Global Health, School of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA 22908, USA.
Clin Infect Dis. 2003 Aug 1;37(3):398-405. doi: 10.1086/376619. Epub 2003 Jul 22.
Cholera drove the sanitary revolution in the industrialized world in the 19th century and now is driving the development of oral rehydration therapy (ORT) in the developing world. Despite the long history of cholera, only in the 1960s and 1970s was ORT fully developed. Scientists described this treatment after the discovery of the intact sodium-glucose intestinal cotransport in patients with cholera. This new understanding sparked clinical studies that revealed the ability of ORT to reduce the mortality associated with acute diarrheal disease. Despite the steady reductions in mortality due to acute dehydrating diarrheal diseases achieved by ORT, the costly morbidity due to these diseases remains, the result of a failure to globalize sanitation and to control the developmental impact of diarrheal diseases and their associated malnutrition. New advances in oral rehydration and nutrition therapy and new methods to recognize its costs are discussed in this review.
霍乱在19世纪推动了工业化世界的卫生革命,如今又在推动发展中世界口服补液疗法(ORT)的发展。尽管霍乱历史悠久,但直到20世纪60年代和70年代,ORT才得到充分发展。科学家们在发现霍乱患者完整的钠-葡萄糖肠道协同转运后描述了这种治疗方法。这一新认识引发了临床研究,揭示了ORT降低急性腹泻病相关死亡率的能力。尽管ORT使急性脱水腹泻病导致的死亡率稳步下降,但这些疾病造成的高昂发病率仍然存在,这是由于卫生设施未能全球化以及未能控制腹泻病及其相关营养不良对发展的影响所致。本文综述了口服补液和营养治疗的新进展以及认识其成本的新方法。